Canagliflozin Prevents Hyperglycemia-Associated Muscle Extracellular Matrix Accumulation and Improves the Adaptive Response to Aerobic Exercise.

"Duality of Interest. No potential conflicts of interest relevant to this article were reported."

"Funding. Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK124258 (to S.J.L.). The work was also supported by a Pilot and Feasibility award granted to S.J.L., and Diabetes Research Center core facilities funded by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases award number P30 DK036836. T.L.M. was supported by a postdoctoral fellowship from the American Heart Association (19POST34381036). P.P. was supported by a Mary K. Iacocca Senior Visiting Fellowship. R.C.N. was supported by a fellowship from Joslin Diabetes Center National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Training Grant T32 DK007260."